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ABSTRACT
Reduction in long-term milk yields represents a no-
table share of the economic losses caused by bovine 
mastitis. Efficient, economic, and safe measures to pre-
vent these losses require knowledge of the causal agent 
of the disease. The aim of this study was to investigate 
pathogen-specific impacts of mastitis on milk produc-
tion of dairy cows. The materials consisted of milk and 
health recording data and microbiological diagnoses of 
mastitic quarter milk samples of 20,234 Finnish dairy 
cows during 2010, 2011, and 2012. The 6 most common 
udder pathogens were included in the study: Staphy-
lococcus aureus, non-aureus staphylococci (NAS), 
Escherichia coli, Corynebacterium bovis, Streptococcus 
uberis, and Streptococcus dysgalactiae. We used a 2-level 
multilevel model to estimate curves for lactations with 
and without mastitis. The data on lactation periods to 
be compared were collected from the same cow. To en-
able comparison among lactations representing diverse 
parities, the estimated lactation curves were adjusted 
to describe the cow’s third lactation. Mastitis caused 
by each pathogen resulted in milk production loss. 
The extent of the reduction depended on the patho-
gen, the timing of mastitis during lactation, and the 
type of mastitis (clinical vs. subclinical). The 2 most 
commonly detected pathogens were NAS and Staph. 
aureus. Escherichia coli clinical mastitis diagnosed 
before peak lactation caused the largest loss, 10.6% 
of the 305-d milk yield (3.5 kg/d). The corresponding 
loss for Staph. aureus mastitis was 7.1% (2.3 kg/d). In 
Staph. aureus mastitis diagnosed between 54 and 120 
d in milk, the loss was 4.3% (1.4 kg/d). The loss was 
almost equal in both clinical and subclinical mastitis 
caused by Staph. aureus. Mastitis caused by Strep. 
uberis and Strep. dysgalactiae resulted in losses ranging 
from 3.7% (1.2 kg/d) to 6.6% (2.1 kg/d) depending on 
type and timing of mastitis. Clinical mastitis caused 
by the minor pathogens C. bovis and NAS also had a 
negative effect on milk production: 7.4% (2.4 kg/d) in 
C. bovis and 5.7% (1.8 kg/d) in NAS when both were 
diagnosed before peak lactation. In conclusion, minor 
pathogens should not be underestimated as a cause of 
milk yield reduction. On single dairy farms, control of 
E. coli mastitis would bring about a significant increase 
in milk production. Reducing Staph. aureus mastitis is 
the greatest challenge for the Finnish dairy sector.
Key words: bovine mastitis, pathogen, milk yield, 
multilevel modeling
INTRODUCTION
Bovine mastitis mainly results from IMI, and is 
mostly derived from common udder pathogens such 
as staphylococci, streptococci, and coliform species 
(Ruegg, 2017). Mastitis results in substantial problems 
in terms of animal welfare, food safety, and profitabil-
ity of milk production. Prevention is always the best 
measure to avoid the negative effects of mastitis. To 
develop efficient incentives for prevention, information 
on the true costs of all types of mastitis is needed. To 
be efficient, economic, and safe, prevention measures 
should be adjusted according to the causal agent be-
cause different approaches are needed to address dif-
ferent pathogens (Lago et al., 2011a,b; Down et al., 
2013; Griffioen et al., 2016). Moreover, public health 
issues have become increasingly important in the milk 
industry because of the fear concerning antimicrobial 
resistance, which increases the pressure to reduce an-
timicrobial drug usage. Prevention and treatment of 
mastitis are the main reasons for antimicrobial drug use 
in the dairy industry (EMA-EFSA, 2017).
Economic losses due to mastitis include direct costs 
due to diagnostic testing, veterinary service, medica-
tion, discarded milk, and labor, as well as indirect costs 
associated with future milk production loss, reduced 
reproduction, and premature culling and replacement 
of mastitic cows (e.g., Santos et al., 2004; Hagnestam-
Nielsen and Østergaard, 2009; Hogeveen et al., 2011; 
Rollin et al., 2015). The costs of preventive measures 
should also be considered in the total costs of mastitis 
(van Soest et al., 2016). The extent of economic loss var-
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ies significantly among countries, depending on factors 
such as milk price, treatment costs, and replacement 
costs (Halasa et al., 2007). Despite country-specific 
variation, long-term milk yield losses constitute a nota-
ble share of the economic losses attributable to mastitis 
(Seegers et al., 2003; Heikkilä et al., 2012; Liang et al., 
2017). Because of evaluation difficulties, particularly 
for indirect costs, dairy farmers typically underestimate 
the costs of mastitis (Huiips et al., 2008). Moreover, 
costs such as the loss of future milk returns are difficult 
to gauge.
The estimated milk yield reduction caused by mastitis 
varies across studies due to differences in follow-up pe-
riods, estimation methods, cattle breeds, management, 
and so on. One reason for the variation in results is the 
use of different diagnostic methods or definitions for 
bovine mastitis and IMI (Andersen et al., 2010; Dohoo 
et al., 2011; Reyher and Dohoo, 2011). The lactation 
phase when the cow becomes infected is critical because 
milk losses are significantly greater in early than in late 
lactation (Hagnestam et al., 2007). High milk yield pre-
disposes cows to mastitis (Oltenacu and Broom, 2010; 
Taponen et al., 2017) but the decrease in milk produc-
tion may be greater than that in less-productive cows 
(Koivula et al., 2005). Clinical and subclinical mastitis 
have different effects on milk production as do different 
mastitis-causing pathogens. Milk yield losses resulting 
from clinical mastitis or high SCC have been studied 
widely (e.g., Rajala-Schultz et al., 1999; Hagnestam-
Nielsen et al., 2009; Detilleux, 2018) but pathogen-spe-
cific research has been limited in scope. In some studies 
carried out in New York State dairy herds, data were 
categorized according to the causal agent into gram-
positive and gram-negative groups and sometimes to 
the species level (Gröhn et al., 2004; Schukken et al., 
2009a; Hertl et al., 2014). Pathogen groups causing the 
greatest losses were gram-negative species, coliforms, 
and streptococci. The pathogens causing the greatest 
losses differed between primiparous and multiparous 
cows (Hertl et al., 2014). Potential effects of minor 
pathogens on milk production are largely unknown. In 
the study of Hertl et al. (2014), clinical mastitis caused 
by CNS did not result in milk yield losses.
Pathogen-specific information is a prerequisite for 
detailed estimation of economic losses and tailored con-
trol of mastitis. Hence, information on the occurrence 
of different mastitis-causing agents in herds is needed. 
Milk sampling for bacteriological diagnostics from all 
or most clinical and subclinical mastitis cases would 
create routinely available data on different causal 
agents. Unfortunately, this practice remains limited in 
many countries where mastitis is treated empirically, 
and mostly without sampling (Griffioen et al., 2016). 
On dairy farms, pathogen information could be used 
to improve mastitis management (Samson et al., 2016). 
For scientific research, it would open new possibilities 
to identify pathogen-specific risk factors and effects of 
mastitis and facilitate development of responsible treat-
ments for introduction on dairy farms.
In Finland, milk sampling in mastitis cases is routine. 
Most mastitic milk samples are analyzed in the labo-
ratories of Valio Ltd. (Helsinki, Finland), where the 
results are recorded in a bacteriological database (Vak-
kamäki et al., 2017). Moreover, 70% of dairy herds and 
80% of dairy cows participate in the Finnish dairy herd 
recording system, where abundant cow- and herd-spe-
cific information is stored (ProAgria, 2017). The aim of 
this study was to investigate pathogen-specific impacts 
of mastitis on milk production of dairy cows. We aimed 
to explain these effects under farm conditions where 
current mastitis control practices are followed. As such, 
the results can be utilized in our upcoming study on 
the pathogen-specific costs of mastitis and the prof-
itability of preventive measures on dairy farms. The 
field data, where the microbiological database of Valio 
Ltd. was merged with the database of the Finnish dairy 
herd recording systems, comprised the materials of the 
study. Six common udder pathogens were included in 
the evaluation of reduction in milk yields.
MATERIALS AND METHODS
Data
The initial materials consisted of data from milk and 
health recordings and microbiological diagnoses of mas-
titic quarter milk samples from 93,529 cows during the 
years 2010, 2011, and 2012. The data are part of the 
broader data set described in Vakkamäki et al. (2017).
Data for cows fulfilling the following criteria were 
included in this study: (1) the cow was of Nordic Red or 
Holstein breed; (2) the data from 2010 to 2012 included 
information from at least 2 lactations of a single cow; 
(3) at least one of the lactations was free from IMI; (4) 
from each cow, 1 to 4 quarter milk samples were sent for 
microbiological analysis to the laboratory of Valio Ltd. 
only once, on the same day; (5) only one pathogen was 
detected in the milk samples from a cow; and (6) the 
pathogen detected was Staphylococcus aureus, non-au-
reus staphylococci (NAS, formerly described as CNS), 
Escherichia coli, Corynebacterium bovis, Streptococcus 
uberis, or Streptococcus dysgalactiae. The number of 
cows fulfilling these criteria was 20,580. After exclud-
ing the cows with missing values, the numbers of cows 
and herds providing data for the study were 20,234 and 
3,953, respectively. The pathogen frequencies among 
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those cows were as follows: NAS, 9,304; Staph. aureus, 
5,160; Strep. uberis, 1,691; Strep. dysgalactiae, 1,604; C. 
bovis, 1,352; and E. coli, 1,123.
The reason for milk sampling was detected or sus-
pected clinical or subclinical mastitis (elevated milk 
SCC) in the quarter. Milk samples were taken by herd 
staff or a supervising veterinarian and submitted to the 
laboratory of Valio Ltd. The bacteriological diagnosis 
was mainly based on a single quarter milk sample. The 
average number of samples per cow was 1.2 for cows 
having NAS or C. bovis, 1.1 for cows with Staph. au-
reus or Strep. dysgalactiae, and 1.0 for cows with Strep. 
uberis or E. coli.
Microbiological diagnoses of quarter milk samples 
from mastitic cows analyzed at the laboratory of Valio 
Ltd. were retrieved from the database of Valio Ltd. 
For microbiological analyses, the PathoProof Mastitis 
PCR Complete-12 assay (Thermo Fisher Scientific, 
Waltham, MA) was used. This test contains oligo-
nucleotides for the staphylococcal β-lactamase gene 
(blaZ) and for the following microbial species or groups 
of species: C. bovis, Enterococcus spp. (including En-
terococcus faecalis and Enterococcus faecium), E. coli, 
Klebsiella oxytoca and Klebsiella pneumoniae, Serratia 
marcescens, Staphylococcus spp., including all major 
NAS, Staph. aureus, Streptococcus agalactiae, Strep. 
dysgalactiae, Strep. uberis, and Trueperella pyogenes/
Peptoniphilus indolicus. In March 2012, the test kit was 
replaced by PathoProof Mastitis PCR Complete-16 as-
say, which also includes Mycoplasma spp., Mycoplasma 
bovis, Prototheca spp., and yeasts.
Milk and health recording data for the cows were 
received from the databases of the Finnish dairy herd 
recording system and the Finnish cattle health moni-
toring system. These data were merged with the data of 
Valio Ltd., resulting in a data set in which microbiologi-
cal results for mastitic milk samples could be analyzed 
with cow-specific information, including breed, date of 
birth, dates of calvings, dates of milk recordings, milk 
yield and SCC for each milk recording, possible masti-
tis diagnosis made by the supervising veterinarian, and 
recorded mastitis treatments.
Statistical Analyses
Our objective was to examine whether mastitis 
caused by a specific pathogen affects milk production 
during lactation with respect to DIM. Information on 
lactation periods with and without mastitis was collect-
ed from the same cow. The estimated lactation curves 
were adjusted to describe the third lactation of a cow. 
In the adjustment, we used weightings derived from the 
results of Lidauer et al. (2000). This procedure enabled 
the comparison of predicted milk yields of the same cow 
for lactation periods with and without mastitis.
The collected variables from each cow were daily milk 
production (response), DIM, type of mastitis (categori-
cal, 2 levels), SCC (categorical, 2 levels), stage (DIM at 
which the pathogen was discovered in the milk sample, 
3 levels), and pathogen (categorical, 6 levels). A dummy 
status predictor defined lactation periods as being with 
or without mastitis. A lactation was defined as being 
with mastitis if a milk sample was sent to the labora-
tory and a pathogen was detected from the sample. A 
lactation was defined as being free of mastitis if no milk 
sample was sent for analysis and no mastitis diagnosis 
and treatment was recorded for the cow.
All milk samples were taken from cows in which herd 
staff had suspected mastitis or observed clinical signs of 
mastitis. In this study, we described the type of disease 
by the diagnosis made by a veterinarian and recorded 
in the Finnish cattle health monitoring system. We 
considered the record of “acute clinical mastitis” ±14 
d from the bacteriological diagnosis of the pathogen 
causing IMI as an indicator of clinical mastitis (CM). 
If such a diagnosis was not made, we recorded that IMI 
had caused subclinical mastitis (SCM). Cows in that 
category had either the diagnosis “subclinical mastitis” 
or no veterinary diagnosis. Milk SCC ±14 d from the 
bacteriological diagnosis was divided into 2 categories 
(≤500,000 cells/mL and >500,000 cells/mL) and was 
also used to describe the type of mastitis. Two vari-
ables measuring the same feature cannot be included in 
the same model and hence we tested the superiority of 
these 2 variables before selecting the final model.
Because the mean of peak lactation of nonmastitic 
lactations was at 53.3 DIM, the first lactation stage 
with increasing milk production was from 1 to 53 DIM 
(“pre” period). The second stage was from 54 to 120 
DIM (“post 1” period) and the third stage from 121 
DIM to next calving, at a maximum 400 DIM (“post 2” 
period). These periods formed the 3 categories indicat-
ing the time of diagnosis with respect to peak produc-
tion.
For each cow, we had several daily milk production 
measurements, up to 14 per lactation (12 per year). For 
an individual cow, the daily milk production values are 
correlated. Furthermore, each cow belongs to a specific 
herd and it is realistic to assume that data for cows 
within the same herd are correlated. Thus, we have 
a multilevel structure of 2 nested levels: cows within 
herds and measurements for each cow within a herd. 
The model response is a vector of milk yield measure-
ments for an individual cow. We applied a 2-level mul-
tilevel model, which can be written as a modification of 
Laird and Ware (1982):
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 yij = Xijβ + Zi,jbi + Zijbij + εij, i = 1, …, M,   
 j = 1, …, Mi [1]
 bi ~ N(0,Ψ1), bij ~ N(0,Ψ2), εij ~ N(0,σ
2I), 
where yij denotes the response vector at the innermost 
level of grouping (individual daily milk production 
measurement for a cow), M is the number of first-level 
groups (number of herds), and Mi is the number of 
second-level groups within the first-level group i (num-
ber of cows within herds i). The length of yij is nij, 
which is the number of milk yield measurements for an 
individual cow j in herd i; β is the p-dimensional vector 
of fixed effects, and the fixed-effects model matrices are 
Xij, i = 1, …, M, j = 1, …, Mi of size nij × p. The 
first-level random effects are bi and the second-level 
random effects are bij, with lengths q1 and q2, respec-
tively; bi represents the deviation from the population 
milk yield mean for herd i and bij represents the de-
viation from herd i milk yield mean for cow j, within 
herd i, for specific predictor values. The corresponding 
model matrices are Zi,j and Zij of sizes nij × q1 and nij 
× q2, respectively. Random effects bi are assumed to be 
normal and independent for different i, and random ef-
fects bij are assumed to be normal and independent for 
different i or j and to be independent of random effects 
bi. Matrices Ψ1 and Ψ2 denote the covariance matrices 
of b_i and b_ij of sizes q_1 × q_1 and q_2 × q_2, 
respectively. The within-group errors εij are assumed to 
be normal and independent for different i or j and to be 
independent of the random effects. Matrix I denotes an 
identity matrix of size n_ij × n_ij. For our model, M 
= 3,953, Mi ranged from 5 to 70, and nij ranged from 1 
to 14 with a median of 10, q1 = 3, q2 =3, and p = 216.
We considered 2 lactation curves that define the 
exact formulation of the 2-level multilevel model: a 
model proposed by Wilmink (1987; equation [2]) and 
a model proposed by Guo and Swalve (1995; equation 
[3]). These models can be written as follows:
 y k DIM DIM= + − ×( )+β β β0 1 2exp ; [2]
 y DIM DIM= + + ( )β β β0 1 2ln . [3]
These model formulations are written at a scalar level 
without subscripts. The models were incorporated into 
the 2-level multilevel model [1] matrices Xij, Zi,j, and 
Zij. We considered every possible interaction of the 
predictors in the model matrix Xij. Because of the ran-
dom structure, we considered random intercept and 
random coefficients with respect to exp(−k × DIM) 
and DIM for Wilmink [2], and random intercept and 
random coefficients with respect to DIM  and ln(DIM) 
for Guo and Swalve [3]. The constant k in the Wilmink 
model [2] was −0.05, based on Wilmink (1987).
Different random and correlation structures were 
used to model the dependence among observations. 
The random structure specifies the mixed-effects pa-
rameters. We considered several cases: random inter-
cept (β0) and “slopes” (β1 and β2); random intercept 
and one slope (β1); and only random intercept and no 
random structure using the notation of the Wilmink 
[2] and Guo and Swalve [3] models. In the multilevel 
model structure, these terms are then incorporated into 
the fixed- and random-effects vectors. The correlation 
structures are used to model the dependence among 
the within-groups errors. For correlation structures, we 
used the first-order autoregressive [AR(1)] and com-
pound symmetry structures; AR(1) assumes that the 
correlation of the observations is larger for observations 
closer to each other in time and diminishes as the time 
lag increases. For the time information, we used both 
DIM and the discrete ordered time points. Compound 
symmetry assumes that the correlation between obser-
vations is constant. We also considered a nonrandom 
model structure, which does not assume correlation 
among any observations. Details of these correlation 
structures can be found, for example, in Pinheiro and 
Bates (2000).
Models were fit first using the method of maximum 
likelihood to allow comparison between models using 
the Akaike information criterion (AIC). When the 
most adequate model was found, the method of REML 
was used to obtain the model parameters.
As model selection and validation tools we used AIC, 
conditional type II and III F-tests, and likelihood ratio 
tests. Conditional F-tests were used to test the signifi-
cance of fixed-effects terms. Likelihood ratio tests were 
used to test significance of terms in the random-effects 
structure. As a goodness-of-fit measure, we used the R2 
(coefficient of determination) described by Nakagawa 
and Schielzeth (2013). They presented marginal and 
conditional R2 coefficients representing the variance 
explained by fixed factors and both fixed and random 
factors, respectively. Finally, model assumptions were 
examined using residual diagnostics.
Missing values were assumed missing completely at 
random or missing at random. Observations for which 
any of the model predictors consisted of missing values 
were omitted from the analysis. Hence, the number of 
valid observations was smaller than the number of cows 
eligible to be modeled.
Because AIC is a meaningful comparison tool only 
for models fit to identical data sets, modeling was first 
conducted on valid observations determined by predic-
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tor SCC, which was the most restrictive predictor with 
respect to missing values. Two Wilmink models, with 
random terms corresponding to β0, β1, and β2 [2], AR(1) 
correlation structure with all predictors except for SCC, 
and with all predictors except for treatment, had essen-
tially the same value for the AIC. The number of cows 
in these analyses providing data was 8,096, indicating 
that for over 50% of the cows in the full data set, there 
were missing values with respect to SCC. This is highly 
problematic and suggests, for example, the possibility 
of selection bias. Because the other predictors did not 
have such a large number of missing values, we consid-
ered the model with all predictors except SCC to be 
more robust. Subsequently, we considered only models 
not including the predictor SCC and fit accordingly 
using valid observations, not restricted by the missing 
values corresponding to SCC.
The model minimizing the AIC was for the Wilm-
ink formulation, including predictors DIM, status, 
treatment, stage, and pathogen, with random terms 
corresponding to β0, β1, and β2 [2] for both herd and 
cow levels and AR(1) correlation structure. Although 
the above model had the minimum AIC, we further 
compared it with similar models with different random 
structures using likelihood ratio testing. The likelihood 
ratio tests suggested that each random term was statis-
tically significant compared with models with 2 random 
slopes, 1 random slope, and no random terms. The sta-
tistical significance of the fixed effects was examined 
via conditional F-tests. Most importantly, the type II 
and III tests corresponding to the 5-way interactions 
were statistically significant for terms β1 and β2 [2], 
providing yet more evidence that each predictor should 
be included in the model.
All computations were performed with R software 
(R Core Team, 2017) using packages car (Fox and 
Weisberg, 2011), MuMIn (Barton, 2017), and nlme 
(Pinheiro et al., 2017).
RESULTS
The results are based on model [1], whose Nakagawa 
marginal and conditional R2 values were 0.39 and 0.67, 
respectively. Thus, almost 40% of the variance in milk 
production was explained by fixed factors only. A sig-
nificant portion of data variability also resided in the 
random factors, which can be seen from the difference 
between the R2 values. Almost 70% of milk production 
variability was explained using both fixed and random 
factors.
Residual diagnostics based on the within-group re-
siduals and fitted values were examined graphically. 
No deficiencies were established regarding homosce-
dasticity or structural violations. The residuals showed 
deviation from normality in the sense of having longer 
tails. Robust or resampling methods could be adopted 
to investigate the effects of the long tails. Such ap-
proaches were not conducted in this study. The random 
terms corresponding to terms β0 and β1 [2] seemed to 
follow the normal distribution at both levels; β2 [2] had 
heavier tails for the cow level and some left-skewness 
for the herd level. There was some correlation between 
the random terms for both levels but it was not statisti-
cally significant.
The 305-d milk yields, estimated by using predictions 
and corresponding confidence intervals, are presented 
in Table 1. The difference between lactations with and 
without mastitis is interpreted to be significant only 
in the categories where the confidence intervals of the 
estimated 305-d yields do not overlap. Supplemental 
Figures S1 to S6 (https: / / doi .org/ 10 .3168/ jds .2018 
-14824) present the predicted lactation curves along 
with pointwise 95% CI for Staph. aureus, NAS, E. coli, 
C. bovis, Strep. uberis, and Strep. dysgalactiae, respec-
tively. The curves are presented separately in relation 
to the type of mastitis (CM, SCM) and the time of 
diagnosis with respect to peak production (pre, post 
1, and post 2 periods). The figures also indicate the 
number of cows in each category. 
Staphylococcus aureus
Staphylococcus aureus accounted for 25.5% of the 
pathogens detected in the cows included in this study. 
The type of mastitis caused by Staph. aureus was 
mainly SCM, which accounted for 77% of all cases 
(Supplemental Figure S1a–f; https: / / doi .org/ 10 .3168/ 
jds .2018 -14824). Staphylococcus aureus mastitis oc-
curred typically either in the beginning of lactation or 
in the end of lactation, 40% before peak lactation and 
41% during the last stage of lactation (post 2 period). 
When Staph. aureus mastitis was diagnosed before 
peak lactation, milk production remained lower than in 
lactations free of mastitis for the entire lactation. The 
difference slightly decreased toward the end of lacta-
tion in the case of CM (Supplemental Figure S1a) but 
remained unchanged with SCM (Supplemental Figure 
S1b). The average daily milk losses calculated until 305 
DIM were 2.3 and 2.2 kg for cows with CM and SCM, 
respectively. Daily milk production for lactations with 
and without mastitis was equal during early lactation 
when the diagnosis was made after peak production 
(post 1 period) for both CM and SCM. After the peak, 
the yield for lactation with mastitis decreased and re-
mained lower than that for lactation free of mastitis, 
regardless of type (Supplemental Figure S1c, d). The 
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average daily milk loss calculated until 305 DIM was 
1.4 kg in both cases. If the diagnosis was made in the 
last stage of lactation (post 2 period), the early lacta-
tion yield was slightly higher for lactation with mastitis 
than for lactation free of mastitis, but at the end of 
lactation the ratio was reversed (Supplemental Figure 
S1e, f).
Mastitis caused by Staph. aureus and diagnosed be-
fore 120 DIM (pre and post 1 periods) resulted in a 
decrease in 305-d milk yield compared with lactation 
without mastitis. The decrease, calculated from the 
point estimates of the yields, was 7.1% of the total 
305-d yield when the diagnosis was made before peak 
lactation. If the diagnosis was made after peak produc-
tion (post 1 period), the proportional reduction in the 
milk yield was 4.3% in CM and 4.4% in SCM (Table 1).
Non-aureus Staphylococci
Non-aureus staphylococci was the most common 
finding (46.0%) among the pathogens included in the 
Table 1. The 305-d milk yield and 95% confidence interval on lactations with mastitis and free of mastitis presented by causative agent, timing 
in lactation, and mastitis type, as well as significant differences in the yield between nonmastitic and mastitic lactations
Pathogen, timing,1 and type 
of mastitis2
305-d milk yield (kg) with 95% CI
 
Significant difference in 305-d yield  
between lactationsLactation with mastitis
 
Lactation free of mastitis
Lower 
bound
Point 
estimate
Upper 
bound
Lower 
bound
Point 
estimate
Upper 
bound
Milk yield 
loss, kg
Milk yield 
loss, %
Milk yield 
loss, kg/d
Staphylococcus aureus
 Pre peak CM 8,994 9,093 9,193 9,682 9,784 9,886 691 7.1 2.3
 Pre peak SCM 8,686 8,868 9,050 9,357 9,542 9,728 674 7.1 2.2
 Post 1 CM 9,221 9,329 9,437 9,653 9,752 9,852 423 4.3 1.4
 Post 1 SCM 9,044 9,222 9,400 9,477 9,648 9,819 426 4.4 1.4
 Post 2 CM 9,572 9,722 9,873 9,608 9,752 9,896    
 Post 2 SCM 9,378 9,628 9,878 9,419 9,661 9,903    
Non-aureus staphylococci
 Pre peak CM 9,114 9,188 9,262 9,668 9,744 9,820 556 5.7 1.8
 Pre peak SCM 9,102 9,300 9,498 9,428 9,630 9,832    
 Post 1 CM 9,202 9,277 9,353 9,511 9,583 9,656 306 3.2 1.0
 Post 1 SCM 9,076 9,255 9,434 9,360 9,533 9,705    
 Post 2 CM 9,484 9,602 9,720 9,436 9,551 9,667    
 Post 2 SCM 9,268 9,541 9,814 9,357 9,622 9,886    
Escherichia coli
 Pre peak CM 8,654 8,874 9,094 9,703 9,927 10,151 1,053 10.6 3.5
 Pre peak SCM 8,691 9,049 9,407 9,242 9,602 9,963    
 Post 1 CM 8,917 9,136 9,355 9,242 9,448 9,654    
 Post 1 SCM 8,837 9,193 9,550 9,199 9,542 9,884    
 Post 2 CM 9,497 9,795 10,092 9,390 9,673 9,956    
 Post 2 SCM 9,033 9,454 9,874 9,095 9,497 9,899    
Corynebacterium bovis
 Pre peak CM 9,042 9,197 9,352 9,770 9,928 10,085 731 7.4 2.4
 Pre peak SCM 8,304 8,842 9,380 9,046 9,592 10,139    
 Post 1 CM 9,036 9,256 9,476 9,137 9,332 9,526    
 Post 1 SCM 8,461 9,017 9,574 9,191 9,674 10,158    
 Post 2 CM 9,540 9,818 10,096 9,357 9,618 9,879    
 Post 2 SCM 9,019 9,623 10,227 9,079 9,649 10,218    
Streptococcus uberis
 Pre peak CM 9,327 9,501 9,674 9,605 9,781 9,956    
 Pre peak SCM 8,798 9,064 9,330 9,441 9,709 9,976 645 6.6 2.1
 Post 1 CM 8,998 9,176 9,353 9,415 9,583 9,751 407 4.2 1.3
 Post 1 SCM 9,136 9,453 9,769 9,511 9,817 10,122    
 Post 2 CM 9,657 9,907 10,157 9,842 10,083 10,325    
 Post 2 SCM 9,091 9,480 9,869 9,168 9,550 9,932    
Streptococcus dysgalactiae
 Pre peak CM 8,989 9,164 9,340 9,605 9,787 9,968 623 6.4 2.0
 Pre peak SCM 8,704 9,023 9,343 9,197 9,522 9,847    
 Post 1 CM 9,082 9,251 9,420 9,449 9,606 9,763 355 3.7 1.2
 Post 1 SCM 9,023 9,333 9,642 9,325 9,631 9,936    
 Post 2 CM 9,596 9,880 10,164 9,512 9,783 10,055    
 Post 2 SCM 9,065 9,546 10,028 9,016 9,492 9,969    
1Pre peak = 1–53 DIM; post 1 = 54–120 DIM; post 2 = >120 DIM.
2CM = clinical mastitis; SCM = subclinical mastitis.
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study. Mastitis caused by NAS was mainly subclinical 
(89%; Supplemental Figure S2a–f; https: / / doi .org/ 10 
.3168/ jds .2018 -14824). It occurred typically either in 
the first or the last stage of lactation, the proportions 
being 44% and 41%, respectively (Supplemental Figure 
S2a–f). The lactation curves for cows with NAS mastitis 
(Supplemental Figure S2a–f) followed the same pattern 
as those for cows with Staph. aureus mastitis (Supple-
mental Figure S1a–f), but the differences between lacta-
tions with mastitis and lactations free of mastitis were 
smaller. When the pathogen was diagnosed before peak 
lactation, the average daily milk loss calculated until 
305 DIM was 1.8 kg for cows with CM (Supplemental 
Figure S2a), but with SCM, we detected no significant 
difference between the lactation curves for lactations 
with and without mastitis (Supplemental Figure S2b). 
For cows diagnosed after peak lactation (post 1 period) 
and having CM, the average daily milk yield loss until 
305 DIM was 1.0 kg (Supplemental Figure S2c).
Mastitis caused by NAS affected 305-d yield when 
the diagnosis was made before or soon after (post 1 
period) peak lactation and the cow was diagnosed with 
CM. The decrease was 5.7% for the earlier-diagnosed 
cow and 3.2% for the later-diagnosed cow (Table 1).
Escherichia coli
Escherichia coli was the causal agent in 5.6% of mas-
titis cases. Mastitis caused by E. coli was clinical in 
28% of cases and diagnosed in 41% of the cases before 
peak lactation (Supplemental Figure S3a–f; https: / / doi 
.org/ 10 .3168/ jds .2018 -14824). The effect of E. coli mas-
titis on daily milk yield was evident for cows diagnosed 
before peak lactation and having CM (Supplemental 
Figure S3a). The average loss until 305 DIM was 3.5 
kg/d and the maximum loss 3.9 kg/d at 61 DIM. When 
the diagnosis of CM was made after the peak (post 
1 period), the pre-peak milk yield was higher than in 
lactation without mastitis, but mastitis caused a sig-
nificant reduction in the yield (Supplemental Figure 
S3c). After the intersection of the lactation curves in 
Supplemental Figure S3c, the total loss until 305 DIM 
was 486 kg (2.3 kg/d). At 305 DIM, the reduction was 
4.6 kg/d, which was the highest daily loss caused by 
the 6 pathogens investigated in the period from 1 to 
305 DIM.
Mastitis caused by E. coli affected 305-d milk yield 
only when the diagnosis was made before peak lacta-
tion and the cow had CM. The decrease was 10.6% of 
the total 305-d yield (Table 1). When the diagnosis was 
made after peak lactation, losses in 305-d yields were 
compensated by the high yields in early lactation.
Corynebacterium bovis
Corynebacterium bovis was detected in 6.7% of the 
cows with mastitis. Half of the mastitis cases caused by 
C. bovis were diagnosed at the end of lactation (post 2 
period). As with NAS mastitis, C. bovis mastitis was 
mainly (89%) subclinical (Supplemental Figure S4a–f; 
https: / / doi .org/ 10 .3168/ jds .2018 -14824). Corynebac-
terium bovis mastitis caused a significant yield loss 
for the whole lactation when the diagnosis was made 
before peak lactation and the cow was diagnosed with 
CM (Supplemental Figure S4a). If the diagnosis was 
made after the peak (post 1 period), the yield in early 
lactation was higher in lactation with mastitis than in 
lactation free of mastitis, but decreased clearly after 
the diagnosis (Supplemental Figure S4c). The average 
daily yield loss for a cow with CM and diagnosed be-
fore peak was 2.4 kg (Supplemental Figure S4a). The 
total loss for lactation with CM after the peak (post 
1 period) was 304 kg (1.9 kg/d) for the period from 
the intersection of the lactation curves until 305 DIM 
(Supplemental Figure S4c).
The effects of C. bovis mastitis on the 305-d yield 
was observed only if the pathogen was diagnosed before 
peak lactation and the cow was diagnosed with CM. 
The loss was 7.4% compared with the lactation free of 
mastitis (Table 1).
Streptococcus uberis
Streptococcus uberis was detected in milk of 8.4% of 
the cows. Clinical cases accounted for 27% of Strep. 
uberis mastitis, which was diagnosed equally (40%) 
before peak production and in the last stage of lacta-
tion (post 2 period; Supplemental Figure S5a–f; https: 
/ / doi .org/ 10 .3168/ jds .2018 -14824). When mastitis 
was caused by Strep. uberis, the curves for lactations 
with and without mastitis were mostly quite close to 
each other (Supplemental Figure S5a–f). However, for 
cows that had SCM and were diagnosed before peak 
lactation, average daily loss until 305 DIM was 2.1 kg 
(Supplemental Figure S5b). The corresponding loss was 
1.3 kg for cows having CM and diagnosed after peak 
lactation (Supplemental Figure S5c).
When mastitis was caused by Strep. uberis, the total 
loss in 305-d yield was 6.6% in the category of cows 
having SCM and diagnosed before peak lactation. 
The corresponding loss for cows diagnosed after peak 
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production (post 1 period) and having CM was 4.2% 
(Table 1).
Streptococcus dysgalactiae
Streptococcus dysgalactiae was detected in milk 
samples of 7.9% of the cows. Mastitis caused by Strep. 
dysgalactiae typically occurred at the beginning of lac-
tation, with 47% of the cases occurring before peak 
lactation (Supplemental Figure S6a–f; https: / / doi .org/ 
10 .3168/ jds .2018 -14824). Clinical cases accounted for 
22% of all Strep. dysgalactiae mastitis cases (Supple-
mental Figure S6a–f). The lactation curves for cows 
with mastitis caused by Strep. dysgalactiae were similar 
to those for cows with mastitis caused by Strep. uberis. 
However, yield losses were slightly smaller when masti-
tis was caused by Strep. dysgalactiae. The average loss 
in daily milk yield was 2.0 kg if the diagnosis of CM 
was made before peak lactation (Supplemental Figure 
S6a) and 1.2 kg if the diagnosis was made after the 
peak (Supplemental Figure S6c).
At the 305-d yield level, the losses were 6.4 and 3.7% 
for cows with CM that were diagnosed before and after 
peak lactation (post 1 period), respectively. When the 
diagnosis was made in the last stage of lactation (post 
2 period), we observed no significant differences in the 
lactation curves or, consequently, in 305-d yields (Table 
1).
DISCUSSION
Our extensive field data from Finnish dairy farms 
provided excellent possibilities to investigate the 
pathogen-specific effects of mastitis on milk produc-
tion. Although we had to adapt the original data set to 
generate appropriate material for the purposes of this 
study, numerous observations were available for each 
pathogen. The data enabled comparison of milk yields 
for lactations with mastitis and those free of mastitis 
from the same cow. Typically, researchers have been 
forced to make comparisons between a cow with mas-
titis and her healthy herdmates (Gröhn et al., 2004; 
Hertl et al., 2014, El-Tarabany and Ali, 2015), which 
may distort the results because cows with mastitis are 
often higher producers before diagnosis than their non-
mastitic herdmates (Gröhn et al., 2004; Hertl et al., 
2014).
Mastitis is an inflammation of the mammary gland 
and always results in decreased production of milk, 
which may be of short duration or can last to the 
end of that lactation period. Histological and other 
analyses have been used to assess the damage to the 
secretory tissue caused by mastitis (Zhao and Lacasse, 
2008). The results clearly indicate that the presence 
of microorganisms (i.e., IMI) is associated with tissue 
damage. Mammary tissue damage reduces the number 
and activity of epithelial cells and, consequently, milk 
production of the quarter is disturbed (Zhao and Lac-
asse, 2008). The mechanisms causing the damage to the 
mammary tissue may differ (Zhao and Lacasse, 2008) 
but the resulting irreversible damage is the main reason 
for the milk loss (Oliver and Calvinho, 1995). More-
over, clear differences exist in pathogenesis between 
bacterial species that cause mastitis. The host immune 
response depends on the invading bacterial species and 
cow-specific factors, and contributes to the severity 
of udder inflammation as well as to the outcomes of 
mastitis, including milk loss (Burvenich et al., 2003; 
Schukken et al., 2011).
Because IMI was detected in milk of every cow in-
cluded in our study, losses in milk yields were expected. 
Pathogen-specific differences in the losses reflect the 
pathogenicity of the detected bacterial species. When 
comparing results of different studies from different 
eras, our results are mainly in line with those of previ-
ous studies. However, some deviations were apparent, 
particularly regarding the effects of minor pathogens.
Staphylococcus aureus is perhaps the most important 
udder pathogen that causes subclinical and clinical 
mastitis with mild to moderate clinical signs (Schukken 
et al., 2011). In our data, the proportions were 72% 
for SCM and 28% for CM. Staphylococcus aureus mas-
titis responds poorly to treatment and often remains 
persistent in the quarter (Barkema et al., 2006). The 
bacterium is able to adhere to epithelium and invade 
the interstitial tissues of the mammary gland, causing 
a deep infection (Schukken et al., 2011). Pathological 
changes in the affected quarter caused by Staph. aureus 
are substantial, in particular if the disease becomes 
chronic (Zhao and Lacasse, 2008).
In our study, Staph. aureus mastitis caused significant 
and long-term loss in milk production. The decrease 
was larger when the diagnosis was made in early lacta-
tion but almost equal in CM and SCM. Our results on 
milk losses and their persistence in Staph. aureus mas-
titis agree with those of earlier studies (Wilson et al., 
1997; Gröhn et al., 2004; Reksen et al., 2007). Gröhn et 
al. (2004) reported that milk loss in Staph. aureus CM 
persisted until at least 70 d after diagnosis. Cows with 
Staph. aureus mastitis already showed a significant de-
crease in milk production up to 30 d before the actual 
case, indicating that CM was a flare-up from SCM. 
More recently, Bobbo et al. (2017) reported a small but 
statistically significant production loss in the case of 
SCM caused by contagious pathogens. In the category 
of contagious pathogens, Staph. aureus alone accounted 
for 88% and Staph. aureus with another pathogen for 
6% of the pathogens detected (Bobbo et al., 2017).
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The most commonly detected pathogens in this study 
were NAS. Our results showed that cows with NAS 
mastitis with a diagnosis of CM (11% of all NAS masti-
tis) produced less milk in lactations with mastitis than 
in those free of mastitis. If the disease occurred at the 
end of lactation, the 305-d yield losses were compen-
sated by the higher yields of early lactation. Subclinical 
mastitis caused by NAS decreased milk production if 
the diagnosis was made between 54 and 120 DIM. If 
NAS SCM was diagnosed earlier or later, an indication 
of production loss, although not statistically signifi-
cant, was seen. Our results are in contrast to those of 
most previous studies. Hertl et al. (2014) investigated 
repeated clinical mastitis episodes in Holstein dairy 
cows and found no association between milk yield loss 
and occurrence of CNS. Similarly, no milk losses were 
attributed to mastitis caused by CNS in 3 other studies 
(Paradis et al., 2010; Tomazi et al., 2015; Bobbo et al., 
2017). Pearson et al. (2013) used data from 19 twin 
pairs to estimate the effects of pericalving CNS mastitis 
in primiparous cows. Again, CNS mastitis was not as-
sociated with decreased milk yield.
Non-aureus staphylococci are traditionally regarded 
as minor pathogens that seem to lack the ability to 
cause severe mastitis (Taponen and Pyörälä, 2009). 
Some studies have even suggested a positive associa-
tion between NAS IMI and milk production (Schukken 
et al., 2009b; Piepers et al., 2013). Cows included in 
those studies, however, differed from those in our study 
because all cows in the herds were sampled, in contrast 
to our study, where only cows with signs of mastitis 
or suspected mastitis were enrolled. Consequently, the 
proportion of NAS originating from the teat canal or 
causing only short-duration IMI was probably high in 
the cited studies, explaining the absence of a negative 
effect on milk yield. Some NAS species affect udder 
health more than others, and the prevalence of NAS 
species may differ between countries (Nyman et al., 
2018). In our study, the mean number of samples for 
cows with NAS or C. bovis mastitis indicated that many 
cows had more than one inflamed quarter. Insignificant 
milk loss in one quarter might thus become significant 
loss at the cow level. Our study does not support the 
existence of a positive milk yield effect related to NAS 
mastitis.
Escherichia coli typically causes acute clinical masti-
tis with moderate to severe clinical signs (Hogan and 
Smith, 2003). In our data, the mean proportion of CM 
was the largest for E. coli (28%). During the middle 
stage of lactation, the proportion was even higher 
(34%). Endotoxin produced by E. coli triggers a rapid 
and strong inflammatory reaction, which results in 
substantial damage to the secretory tissue (Schukken 
et al., 2011). Consequently, a significant decrease in 
milk production ensues, which may continue until the 
end of lactation (Burvenich et al., 2003; Zhao and Lac-
asse, 2008). In our study, the most severe and sudden 
decrease in milk production was recorded for cows with 
E. coli mastitis. The significant milk loss due to E. coli 
mastitis has been verified by Gröhn et al. (2004) and 
Hertl et al. (2014). If the diagnosis of CM caused by 
E. coli was made after 53 DIM in our study, the daily 
milk yield of lactation with upcoming mastitis was ini-
tially higher than that of a lactation free of mastitis. 
In general, dairy cows with high milk yields are more 
prone to mastitis than those with low yields, but this 
phenomenon was common to all pathogens considered 
in this study except C. bovis (Taponen et al., 2017). 
Hence, a special susceptibility to mastitis due to E. coli 
because of high production does not explain this result.
Corynebacterium bovis has been regarded as a minor 
pathogen that causes only a slight increase in milk SCC 
and rarely clinical mastitis (Djabri et al., 2002). It has 
been considered a colonizer of the teat canal (Bexiga et 
al., 2011). However, in a study in which quarter milk 
samples were taken both via the teat canal and directly 
from the udder cistern, C. bovis was detected in both 
sites in almost equal numbers, indicating that it does 
cause mastitis (Hiitiö et al., 2016). Our study showed 
that C. bovis is able to cause CM, although the propor-
tion of CM was, along with the CM proportion of NAS, 
the lowest (11%) among the pathogens studied.
Very little is known about the effect of mastitis due 
to C. bovis on milk production. This bacterium has 
not been a major focus and relevant data may have 
been pooled with other “less important” pathogens. 
However, Wilson et al. (1997) reported that 305-d milk 
production of cows with C. bovis in composite milk 
was lower (9,002 kg) than that of cows without any 
isolated pathogens (9,578 kg). In contrast, Gonçalves 
et al. (2016) reported that subclinical C. bovis infection 
had no effect on milk yield. In the present study, we 
showed that mastitis caused by C. bovis is associated 
with milk losses. Our results indicated a larger propor-
tional decrease (7.4 vs. 6.0%) in 305-d milk yield than 
did Wilson et al. (1997), providing that C. bovis was 
detected before peak lactation and the cow was diag-
nosed with CM. Based on our results, C. bovis deserves 
more attention, although milk losses caused by C. bovis 
mastitis were significant only in CM.
Streptococcus uberis and Strep. dysgalactiae are 
common udder pathogens causing subclinical masti-
tis and clinical mastitis with moderate clinical signs 
(Leigh, 1999; Rato et al., 2011). Streptococcus uberis 
has received more attention because of its pathogenic 
characteristics and ability to cause persistent or re-
current infections (Pedersen et al., 2003; Milne et al., 
2005). Milk losses from IMI caused by Strep. uberis and 
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Strep. dysgalactiae have seldom been studied separately 
but the species have been included in the group of 
Streptococcus spp. We found that both species caused 
moderate production losses, but Strep. uberis more 
than Strep. dysgalactiae. In the study of Gröhn et al. 
(2004), milk yield losses caused by Streptococcus spp. 
were among the most significant, together with those 
caused by E. coli and Staph. aureus. Hertl et al. (2014) 
also indicated that production losses resulted from CM 
caused by Streptococcus spp. Mastitis caused by Strep. 
uberis was associated with a lower milk yield in the 
twin pairs comparison of Pearson et al. (2013).
Milk losses were greater if a cow had CM compared 
with SCM. The only exception was for Staph. aureus, 
which caused almost equal losses regardless of the type 
of mastitis. Differences between CM and SCM were 
expected because CM affects the general health of 
the cow and causes pathological changes in the udder, 
which can be severe. Cows suffering from CM prob-
ably received antimicrobial treatment and, in moder-
ate or severe cases, also supportive therapy (Barlow, 
2011). In SCM, treatment may often be postponed 
until drying-off (Barlow, 2011). In our study, treatment 
of CM probably affected the outcome of mastitis and 
decreased production losses by relieving clinical signs 
and shortening the duration of the disease. Nonethe-
less, the difference between CM and SCM remains. 
Poor prognosis to eliminate IMI is generally associated 
with Staph. aureus mastitis (Barkema et al., 2006). In 
the current study, milk loss due to Staph. aureus CM 
slightly decreased to the end of lactation (Supplemental 
Figure S1a), in contrast to SCM (Supplemental Figure 
S1b). This could result from a treatment effect but 
might also indicate that the stronger host response in 
Staph. aureus CM was able to support elimination of 
IMI more efficiently than in SCM, which often may be 
of chronic nature. Clinical mastitis caused by penicillin-
susceptible Staph. aureus responds well to penicillin, 
which is the treatment of choice in Finland (Taponen 
et al., 2003).
In this study, our aim was to investigate production 
losses at the cow level to produce appropriate data for 
economic analysis rather than to indicate a treatment 
response. Differences in numbers of quarters infected 
with the 6 pathogens studied and antimicrobial treat-
ments given to cows might have affected the results. 
However, it is in line with our purpose to show the 
effect of pathogen-specific mastitis on milk production 
as it appears in Finnish dairy herds.
CONCLUSIONS
In terms of milk yield losses, the most harmful 
pathogen causing mastitis is E. coli. The milk yield 
reduction resulting from the presence of E. coli was 
both large and long lasting. However, this result is valid 
only at the cow level because E. coli is the least com-
mon pathogen among the 6 most common pathogens 
detected in Finnish dairy herds and investigated in 
this study. Corynebacterium bovis proved to be a more 
harmful pathogen than expected when causing CM 
because it can cause milk losses comparable to those of 
Staph. aureus. When considering the entire dairy sec-
tor, the largest milk yield losses result from mastitis 
due to the widespread pathogen Staph. aureus, which 
causes moderate yield losses with both CM and SCM. 
The NAS have a substantial negative impact because 
they are very common and can reduce milk produc-
tion, especially when associated with CM. Streptococ-
cus uberis and Strep. dysgalactiae belong to the middle 
category, in terms of both frequency and loss of milk 
production. Milk yield losses are invariably larger the 
earlier in lactation the diagnosis is made. With late 
onset of mastitis, daily milk yields for early lactations 
may be even higher for lactations with mastitis than 
for those without. We conclude that mastitis caused by 
the pathogens investigated in this study results in re-
duced milk yield on Finnish dairy farms. The extent of 
the reduction depends on the causal agent, the timing 
of mastitis within a lactation, and the type of disease 
(clinical or subclinical). The minor pathogens should 
not be underestimated as causes of milk production 
losses. On single dairy farms, control of E. coli mastitis 
would bring about a significant increase in milk pro-
duction. Reducing Staph. aureus mastitis is the greatest 
challenge for the dairy sector.
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